Table 1.
Clinical and anthropometric features of patients (n = 56) and controls (n = 26). Data are expressed as Mean +/- SD (min; max)
Patients | Controls | |
---|---|---|
Age (years) | 65 +/- 9 (39; 80) | 62 +/- 8 (48; 76) |
Height (cm) | 153 +/- 0.06 (135; 165) | 152 +/- 0.05 (142; 159) |
Weight (kg) | 63.83 +/- 9.43 (51; 86) | 64.73 +/- 11.06 (51; 83) |
Body mass index (kg/m2) | 26.88 +/- 4.49 (19.34; 34.78) | 27.70 +/- 3.55 (22.5; 34.58) |
Total hip BMD (g/cm2)* | 0.701 +/- 0.07 (0.460; 0.790) | 0.990 +/- 0.10 (0.890; 1.300) |
Total hip T-score* | −3.0 +/- 0.7 (-5.4; -2.0) | −0.1 +/- 1.0 (-1.1; 3.0) |
Total hip Z-score* | −1.1 +/- 0.9 (-3.3; 0.2) | 1.4 +/- 1.1 (-0.5; 4.0) |
Calcanear QUS T-score * | −3.6 +/- 0.92 (-5.5; -1.79) | −0.73 +/- 1.26 (-2.3; 2.5) |
ESR (mm/h)* | 19.25 +/- 8.69 (6; 44) | 12 +/- 7.56 (2; 27) |
CRP (mg/L)* | 5.75 +/- 6.60 (0.1; 41) | 2.67 +/- 3.65 (0.1; 19) |
BAP (μg/L) | 17.68 +/- 6.57 (8.2; 30.8) | 15.26 +/- 7.00 (5; 30.8) |
CTX (pg/mL)* | 380 +/- 246 (0.32; 900) | 155 +/- 236 (5; 568)) |
PTH (pg/mL) | 67.03 +/- 22.59 (28.6; 147) | 66.04 +/- 15.20 (42.5; 88) |
Legend: erythrocyte sedimentation rate (ESR); C-reactive protein (CRP); bone alkaline phosphatase (BAP)
; C-telopeptide cross-linked collagen type 1 (CTX); parathyroid hormone (PTH)
*Statistically significant difference between patients and controls (p < 0.001)